0001104659-25-079619.txt : 20250818 0001104659-25-079619.hdr.sgml : 20250818 20250818104007 ACCESSION NUMBER: 0001104659-25-079619 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250818 DATE AS OF CHANGE: 20250818 EFFECTIVENESS DATE: 20250818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Entero Therapeutics, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 464993860 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-555023 FILM NUMBER: 251226781 BUSINESS ADDRESS: STREET 1: 777 YAMATO ROAD STREET 2: SUITE 502 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 561-589-7020 MAIL ADDRESS: STREET 1: 777 YAMATO ROAD STREET 2: SUITE 502 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: First Wave BioPharma, Inc. DATE OF NAME CHANGE: 20210921 FORMER COMPANY: FORMER CONFORMED NAME: AzurRx BioPharma, Inc. DATE OF NAME CHANGE: 20141103 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 D 1 primary_doc.xml X0708 D LIVE 0001604191 Entero Therapeutics, Inc. 79014TH ST N # 21135 ST. PETERSBURG FL FLORIDA 33702 561-589-7020 DELAWARE None First Wave BioPharma, Inc. AzurRx BioPharma, Inc. BioPharma d'Azur, Inc. Corporation true Richard Paolone 79014th St N # 21135 St. Petersburg FL FLORIDA 33702 Executive Officer Director Edward Borkowski 79014th St N # 21135 St. Petersburg FL FLORIDA 33702 Director Eric Corbett 79014th St N # 21135 St. Petersburg FL FLORIDA 33702 Director Manpreet Uppal 79014th St N # 21135 St. Petersburg FL FLORIDA 33702 Director Jack Syage 79014th St N # 21135 St. Petersburg FL FLORIDA 33702 Director Anna Skowron 79014th St N # 21135 St. Petersburg FL FLORIDA 33702 Executive Officer Jason Sawyer 79014th St N # 21135 St. Petersburg FL FLORIDA 33702 Director Geordan Pursglove 79014th St N # 21135 St. Petersburg FL FLORIDA 33702 Director Biotechnology Decline to Disclose 06b false 2025-08-09 false true true false 0 3025000 3025000 0 false 3 0 0 0 true Some of the proceeds may be used for general corporate purposes including the payment of salaries and other fees to those listed in Item 3. false Entero Therapeutics, Inc. /s/ Richard Paolone Richard Paolone Interim Chief Executive Officer 2025-08-18